Genomic medicine in non-small cell lung cancer: paving the path to personalized care.

作者: Krishna Bajee SRIRAM , Jill Everland LARSEN , Ian Anthony YANG , Rayleen Veronica BOWMAN , Kwun Meng FONG

DOI: 10.1111/J.1440-1843.2010.01892.X

关键词:

摘要: Lung cancer is the commonest cause of cancer-related mortality and non-small cell lung (NSCLC) accounts for 80% all cancer. The prognosis NSCLC remains poor across stages, despite advances in staging techniques treatments. findings recent high-throughput mRNA microarray studies have shown potential refining current diagnosis, classification, treatment paradigms. Emerging microRNA, DNA copy number methylation profiles are also providing novel insights into biology NSCLC. Currently there several challenges, such as reproducibility cost platforms that will need to be addressed prior implementation these genomic technologies routine thoracic oncology practice. In addition, tests (such prediction gene expression signatures) validated well designed prospective aim answer clinically relevant questions. If successful, integration microarray-based information with existing clinicopathological models may enhance ability clinicians match most effective an individual patient. Such a strategy improve survival reduce treatment-related morbidity patients.

参考文章(71)
S Petersen, M Aninat-Meyer, K Schlüns, K Gellert, M Dietel, I Petersen, Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. British Journal of Cancer. ,vol. 82, pp. 65- 73 ,(2000) , 10.1054/BJOC.1999.0878
Justin M Balko, Anil Potti, Christopher Saunders, Arnold Stromberg, Eric B Haura, Esther P Black, Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors. BMC Genomics. ,vol. 7, pp. 289- 289 ,(2006) , 10.1186/1471-2164-7-289
Shuta Tomida, Katsumi Koshikawa, Yasushi Yatabe, Tomoko Harano, Nobuhiko Ogura, Tetsuya Mitsudomi, Masato Some, Kiyoshi Yanagisawa, Toshitada Takahashi, Hirotaka Osada, Takashi Takahashi, Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients Oncogene. ,vol. 23, pp. 5360- 5370 ,(2004) , 10.1038/SJ.ONC.1207697
Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber, Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer. ,vol. 7, pp. 169- 181 ,(2007) , 10.1038/NRC2088
M. Schena, D. Shalon, R. W. Davis, P. O. Brown, Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray Science. ,vol. 270, pp. 467- 470 ,(1995) , 10.1126/SCIENCE.270.5235.467
Rafael Rosell, Enriqueta Felip, Luis Paz-Ares, None, How could pharmacogenomics help improve patient survival Lung Cancer. ,vol. 57, ,(2007) , 10.1016/S0169-5002(07)70426-9
M. E. Garber, O. G. Troyanskaya, K. Schluens, S. Petersen, Z. Thaesler, M. Pacyna-Gengelbach, M. van de Rijn, G. D. Rosen, C. M. Perou, R. I. Whyte, R. B. Altman, P. O. Brown, D. Botstein, I. Petersen, Diversity of gene expression in adenocarcinoma of the lung Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 13784- 13789 ,(2001) , 10.1073/PNAS.241500798
David G. Beer, Sharon L.R. Kardia, Chiang-Ching Huang, Thomas J. Giordano, Albert M. Levin, David E. Misek, Lin Lin, Guoan Chen, Tarek G. Gharib, Dafydd G. Thomas, Michelle L. Lizyness, Rork Kuick, Satoru Hayasaka, Jeremy M.G. Taylor, Mark D. Iannettoni, Mark B. Orringer, Samir Hanash, Gene-expression profiles predict survival of patients with lung adenocarcinoma Nature Medicine. ,vol. 8, pp. 816- 824 ,(2002) , 10.1038/NM733
Nozomu Yanaihara, Natasha Caplen, Elise Bowman, Masahiro Seike, Kensuke Kumamoto, Ming Yi, Robert M. Stephens, Aikou Okamoto, Jun Yokota, Tadao Tanaka, George Adrian Calin, Chang-Gong Liu, Carlo M. Croce, Curtis C. Harris, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell. ,vol. 9, pp. 189- 198 ,(2006) , 10.1016/J.CCR.2006.01.025